• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭穿宫颈癌中的神话与错误信息:关于局部晚期病例复杂治疗选择及探索标准方案之外治疗方法的叙述性综述

Debunking Myths and Misinformation in Cervical Cancer: A Narrative Review on Navigating Complex Treatment Choices in Locally Advanced Cases and Exploring Beyond Standard Protocols.

作者信息

Muallem Mustafa Zelal, Sayasneh Ahmad

机构信息

Department of Gynecology with Center for Oncological Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Virchow Campus Clinic, Charité Medical University, 13353 Berlin, Germany.

Department of Gynecological Oncology, Guy's and St Thomas' NHS Foundation Trust, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, Westminster Bridge Road, London SE1 7EH, UK.

出版信息

Diagnostics (Basel). 2025 May 6;15(9):1174. doi: 10.3390/diagnostics15091174.

DOI:10.3390/diagnostics15091174
PMID:40361992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072022/
Abstract

Cervical cancer remains a significant health challenge globally, with locally advanced cervical cancer (LACC) representing a particularly complex subset due to its diverse definitions and varied treatment approaches. The absence of randomized controlled trials comparing the upfront radical surgery followed by concurrent chemoradiotherapy (CCRT) or chemotherapy alone for clearly defined risk factors for LACC hinders the development of standardized treatment protocols, leading to disparities in patient outcomes across different healthcare settings. This paper seeks to underline the necessity of a consensus on the definition of LACC and aims to comprehensively and critically review the existing literature trying to harmonize treatment strategies and improve prognostic outcomes. Our analysis suggests a multimodal approach for treating FIGO IB3, IIA2, and selected IIB cases at facilities capable of delivering highly curative nerve-sparing surgical interventions, with the goal of bridging the gap in current treatment methodologies. Preliminary findings suggest that adopting a standardized definition could facilitate more consistent treatment outcomes and enhance comparative research.

摘要

宫颈癌仍然是全球一项重大的健康挑战,局部晚期宫颈癌(LACC)由于其定义多样和治疗方法各异,是一个特别复杂的亚组。由于缺乏针对LACC明确定义的危险因素,比较 upfront 根治性手术联合同步放化疗(CCRT)或单纯化疗的随机对照试验,阻碍了标准化治疗方案的制定,导致不同医疗环境下患者的治疗结果存在差异。本文旨在强调对LACC定义达成共识的必要性,并旨在全面、批判性地回顾现有文献,以协调治疗策略并改善预后。我们的分析表明,对于能够提供高治愈率的保留神经手术干预的机构,应采用多模式方法治疗FIGO IB3、IIA2和部分IIB病例,目标是弥合当前治疗方法的差距。初步研究结果表明,采用标准化定义有助于获得更一致的治疗结果并加强比较研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d441/12072022/a2389177d85d/diagnostics-15-01174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d441/12072022/a2389177d85d/diagnostics-15-01174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d441/12072022/a2389177d85d/diagnostics-15-01174-g001.jpg

相似文献

1
Debunking Myths and Misinformation in Cervical Cancer: A Narrative Review on Navigating Complex Treatment Choices in Locally Advanced Cases and Exploring Beyond Standard Protocols.揭穿宫颈癌中的神话与错误信息:关于局部晚期病例复杂治疗选择及探索标准方案之外治疗方法的叙述性综述
Diagnostics (Basel). 2025 May 6;15(9):1174. doi: 10.3390/diagnostics15091174.
2
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.根治性子宫切除术联合放化疗与单纯根治性子宫切除术治疗局部晚期宫颈癌的疗效比较
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD010260. doi: 10.1002/14651858.CD010260.pub3.
3
Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.FIGO 分期(2019)IB3/II 期宫颈癌行肿瘤细胞减灭术联合放化疗与单纯放化疗的比较。
Cochrane Database Syst Rev. 2022 Sep 16;9(9):CD012246. doi: 10.1002/14651858.CD012246.pub2.
4
Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.基于 2018 年 FIGO 分期的同步放化疗加或不加辅助化疗治疗局部晚期宫颈癌的生存预测列线图:一项回顾性分析。
Cancer Biother Radiopharm. 2024 Nov;39(9):690-705. doi: 10.1089/cbr.2023.0199. Epub 2024 Jun 3.
5
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
6
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.局部晚期宫颈癌同步放化疗后的辅助化疗。
Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010401. doi: 10.1002/14651858.CD010401.pub2.
7
A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial).特定局部晚期宫颈癌(IB3 期、IIA2 期、IIICr 期)患者同期放化疗与根治性手术的比较:一项随机对照研究(C-CRAL 试验)的试验方案。
J Gynecol Oncol. 2023 Sep;34(5):e64. doi: 10.3802/jgo.2023.34.e64. Epub 2023 Jun 20.
8
A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.多机构回顾性分析同步放化疗后接受铂类辅助化疗的局部晚期宫颈癌患者的肿瘤学结局。
Cancer Control. 2021 Jan-Dec;28:1073274821989307. doi: 10.1177/1073274821989307.
9
Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis.放化疗联合免疫检查点抑制剂治疗局部晚期宫颈癌的疗效和安全性:系统评价和荟萃分析。
Front Immunol. 2024 Sep 16;15:1459693. doi: 10.3389/fimmu.2024.1459693. eCollection 2024.
10
Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.由于缺乏放疗设备,采用新辅助化疗后行根治性手术治疗 FIGO 2018 期 IB3/IIA2 宫颈癌的临床结局:与同期放化疗的回顾性比较。
PLoS One. 2022 Mar 24;17(3):e0266001. doi: 10.1371/journal.pone.0266001. eCollection 2022.

本文引用的文献

1
Should all cervical cancer patients with positive lymph node receive definitive radiotherapy: a population-based comparative study.所有淋巴结阳性的宫颈癌患者都应接受根治性放疗吗:一项基于人群的比较研究。
Arch Gynecol Obstet. 2025 Jan;311(1):123-134. doi: 10.1007/s00404-024-07896-2. Epub 2025 Jan 3.
2
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.帕博利珠单抗或安慰剂联合放化疗,随后行帕博利珠单抗或安慰剂巩固治疗新诊断的、高危、局部晚期宫颈癌(ENGOT-cx11/GOG-3047/KEYNOTE-A18):一项随机、双盲、III 期临床研究。
Lancet. 2024 Apr 6;403(10434):1341-1350. doi: 10.1016/S0140-6736(24)00317-9. Epub 2024 Mar 20.
3
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.度伐利尤单抗联合放化疗对比安慰剂用于局部晚期宫颈癌(CALLA)的随机、双盲、III 期临床试验
Lancet Oncol. 2023 Dec;24(12):1334-1348. doi: 10.1016/S1470-2045(23)00479-5.
4
Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study.2018 年 FIGO 分期方案时代高风险人群中手术治疗的宫颈癌:一项全国性研究。
Sci Rep. 2023 Jul 25;13(1):12020. doi: 10.1038/s41598-023-39014-8.
5
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.ESGO/ESTRO/ESP 宫颈癌管理指南-2023 年更新版。
Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429.
6
Survival outcome of cervical cancer patients treated by image-guided brachytherapy: a 'real world' single center experience in Thailand from 2008 to 2018.2008 年至 2018 年泰国单中心图像引导近距离放疗宫颈癌患者生存结局的真实世界研究
J Radiat Res. 2022 Jul 19;63(4):657-665. doi: 10.1093/jrr/rrac025.
7
Rethinking the significance of surgery for uterine cervical cancer.重新思考宫颈癌手术的意义。
J Obstet Gynaecol Res. 2022 Mar;48(3):576-586. doi: 10.1111/jog.15112. Epub 2021 Dec 14.
8
Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.亡羊补牢,为时未晚:近距离放疗在局部晚期宫颈癌治疗中的重要性优于时机。
Gynecol Oncol. 2022 Feb;164(2):348-356. doi: 10.1016/j.ygyno.2021.11.015. Epub 2021 Dec 3.
9
Cancer of the cervix uteri: 2021 update.子宫颈癌:2021 年更新。
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865.
10
A New Anatomic and Staging-Oriented Classification of Radical Hysterectomy.一种新的基于解剖学和分期的根治性子宫切除术分类法。
Cancers (Basel). 2021 Jul 2;13(13):3326. doi: 10.3390/cancers13133326.